Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd., a leader in 3D-printed medical implants, has partnered with Singapore’s largest public hospital cluster, SingHealth, to create its first Global Centre of Excellence (GCoE) for customised medical devices. This pioneering GCoE will be a hub for innovation, allowing Osteopore to co-develop, test, and globally scale its medical devices, potentially improving patient outcomes and reducing healthcare costs. The partnership, supported by a Singapore government grant covering up to 70% of costs, is expected to be fully operational by the second half of 2026.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
